On June 4, 2025, the U.S. Department of Health and Human Services Office of Research Integrity (“ORI”) published a Sample Policies and Procedures for Addressing Allegations of Research Misconduct ...
Sham controls can be integral to CV device trials, providing a unique way to overcome the placebo effect, but they also present an ethical minefield of concerns that merit close consideration, a new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results